11:45 AM EDT, 05/03/2024 (MT Newswires) -- Tandem Diabetes Care ( TNDM ) shares surged nearly 22% in recent Friday trading, a day after the company reported Q1 sales that exceeded market expectations.

The company reported Q1 net loss Thursday of $0.65 per diluted share, narrowing from $1.92 a year earlier.

Analysts polled by Capital IQ expected a loss of $0.77.

Sales for the quarter ended March 31 were $191.7 million, up from $169.4 million a year earlier.

Analysts surveyed by Capital IQ expected $173.5 million.

The company expects non-GAAP sales of $205 million in Q2 and $868 million in 2024. Analysts surveyed by Capital IQ expect $206.3 million and $864.6 million, respectively.

Price: 44.50, Change: +7.94, Percent Change: +21.72